May 15, 2020
Top 3 Ways to Use Tumor Organoids for Drug Screening
Explore the top 3 ways to use tumor organoids for drug screening: library screening, efficacy quantification screening, and combination strategy screening.
LEARN MORE
May 7, 2020
Top 4 Applications for Tumor Organoids in Oncology Drug Development
Explore the main applications for tumor organoids in preclinical cancer drug development, driven by the unique features ...
LEARN MORE
May 5, 2020
HUB Organoids as Human Cancer Models
Explore the phenotypic and genetic concordance between HUB patient-derived tumor organoids and the primary human ...
LEARN MORE
April 30, 2020
How to Use Tumor Organoids for Immuno-Oncology Applications
Explore how to use tumor organoids for immuno-oncology applications, including immunotherapy assessment through ...
LEARN MORE
April 28, 2020
PARP Inhibitors: Where Are We in 2020 and What’s Coming Next?
Review the current approval status of PARP inhibitors, and what could be coming next for this class of agent, including ...
LEARN MORE
April 24, 2020
Modeling Oncogenic RAS and BRAF Mutations Using Colorectal Cancer Organoids
Explore how genetically engineered patient-derived tumor organoids are helping to model colorectal cancer and specific ...
LEARN MORE
April 22, 2020
The Role of Proteomics in Oncology Biomarker Discovery
Explore the evolving role of proteomics in oncology biomarker discovery, specifically identifying and analyzing biomarkers in cancer drug development.
LEARN MORE
April 1, 2020
The Role of Patient-Derived Tumor Organoids in Precision Medicine
Explore how patient-derived tumor organoids are used in the clinic to develop novel precision medicine approaches for ...
LEARN MORE
March 16, 2020
Tumor Organoid Q&A: PDXO Models and Immuno-Oncology Applications
Review the key questions and answers on PDX-derived organoids (PDXO) and tumor organoid immuno-oncology applications ...
LEARN MORE
March 12, 2020
Top 10 Questions: HUB Organoid Technology and Models
Dr Rajendra Kumari answers the key questions around HUB Organoid technology and tumor organoid models from our recent ...
LEARN MORE
March 11, 2020
Top 10 Questions: Liver-Targeted Mitochondrial Uncoupling in NHP Models
Dr. Leigh Goedeke, Postdoctoral Fellow at Yale School of Medicine answers the most popular questions from her recent fatty liver disease webinar, covering liver-targeted mitochondrial uncoupling proof of concept studies in NHP models.
LEARN MORE
March 6, 2020
How to Develop Predictive Cancer Biomarkers
How to develop predictive cancer biomarkers: Explore the different types and classes of cancer biomarker, and the key ...
LEARN MORE
March 5, 2020
Comparison Guide: Carbon Tetrachloride Induction and Choline Deficient Diet Models
Compare the key features of popular commercial mouse models for accelerated NAFLD and NASH including fibrosis, such as ...
LEARN MORE
February 27, 2020
The Benefits of PDX Models in Head and Neck Cancer Research
Explore why patient-derived xenografts (PDX) are an important model in head and neck cancer research, particularly for ...
LEARN MORE
February 25, 2020
Using Organoids to Understand Colorectal Cancer Mechanisms and Development
Learn how healthy tissue and tumor-derived organoids are used to uncover disease mechanisms, here shining a light on ...
LEARN MORE
